Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B

dc.article.end-page3057en
dc.article.start-page3049en
dc.citation.doi10.1182/BLOODADVANCES.2022009230en
dc.contributor.authorA Shapiroen
dc.contributor.authorR Kulkarnien
dc.contributor.authorM Ragnien
dc.contributor.authorH Chambosten
dc.contributor.authorJohnny Mahlanguen
dc.contributor.authorE et alen
dc.date.accessioned2024-07-23T05:54:05Z
dc.date.available2024-07-23T05:54:05Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2473-9529en
dc.identifier.urihttps://hdl.handle.net/10539/39018
dc.journal.titlePost hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia Ben
dc.journal.volume7en
dc.titlePost hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia Ben
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
216.04 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client